CLINICAL_TRIALS
withdrawal
· 2017-11-24
Clinical Trial Update: Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluating adipose-derived stem cells for chronic obstructive pulmonary disease was withdrawn; no results are reported and the sponso…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ageless Regenerative Institute | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1, Phase 2 | Status: WITHDRAWN